Cathie Wood is resolute on RXRX despite its slump. Should investors follow her lead into this AI-driven biotech bet now?

Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...

Galectin Therapeutics Inc. is rated a Hold due to absence of finalized agreement with FDA, combined with a tight runway. Read ...

A remarkable advancement in microbial engineering has put a previously obscure natural pigment in the spotlight.

Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the appointment of Andrew Levin, M.D., Ph.D., ...

Here are seven biopharma-related trends for 2026 that have emerged from GEN interviews with experts and other industry stakeholders, and from reviews of reports and public statements.

Study demonstrated that the Homer1 gene improves focus by reducing “noise” in the prefrontal cortex, with implications for studying attention disorders.

LBL-047 (DNTH212) is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, ...

Green Thumb, Tilray, and Trulieve will be helped by rescheduling marijuana, but investors should also consider other factors. These cannabis companies could soon see more green thanks to the president ...

Zimmer Biomet is changing surgical robotics by integrating AI and data-driven solutions to enhance precision and patient ...

A study led by researchers at the Department of Civil Engineering at The University of Hong Kong (HKU) has uncovered alarming ...

A small group of volunteers will receive multiple injections of the experimental treatments next month, says Unlimited Bio.